TearLab (TEAR) to Participate in the 10th Annual Craig-Hallum Conference

SAN DIEGO, May 23, 2013 (GLOBE NEWSWIRE) — TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) (“TearLab” or the “Company”) announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company’s business at the 10th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 29, 2013 at 9:20 a.m. Central Time. The conference will be held at the Minneapolis Marriott City Center.

Mr. Vamvakas’ presentation will not be webcast. Portfolio managers and analysts who wish to request a meeting with the Company at the conference should contact their Craig-Hallum sales representative.

About TearLab Corporation

TearLab Corporation (www.tearlab.com) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab® Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation’s common shares trade on the NASDAQ Capital Market under the symbol ‘TEAR’ and on the Toronto Stock Exchange under the symbol ‘TLB.’

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about TearLab. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our annual and quarterly reports on Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.

CONTACT: Investors:
         Stephen Kilmer
         (647) 872-4849
         skilmer@tearlab.com

         Media:
         Leonard Zehr
         Managing Director
         Kilmer Lucas Inc.
         (416) 833-9317
         leonard@kilmerlucas.com